Why this matters (India lens) * Injectables = device + cold chain + cost * Oral = manufacturing + distribution advantage * Post patent wave crowded market, sharper differentiation needed My take The next winners wont be just best molecule
When used responsibly and in the recommended dosage, glutathione is considered safe
Four years ago, my husband and I purchased a house in Boston, where we were excited to start a family and make our new house a home, Dustin said
Imfinzi (durvalumab) Disease area(s): Oncology Manufacturer(s): AstraZeneca 2024 Sales (USD): $4.72 billion Why it sold so well: In 2024, AstraZenecas Imfinzi experienced strong sales growth, driven by expanded indications and robust clinical trial results
USD 39.95 Prices may be subject to local taxes which are calculated during checkout Similar content being viewed by others References Unger, R